Companies
SomaGenics: $2.275M in NIH grants, four patents, and more
![](https://www.santacruztechbeat.com/wp-content/uploads/2014/12/SomaGenics.png)
Sara Isenberg
Santa Cruz Tech Beat, Publisher
Translating RNA discoveries into innovative products
Santa Cruz Tech Beat published Six Companies to Watch in the Emerging Santa Cruz Biotech Hub almost a year ago (February 27, 2014).
SomaGenics was one of those companies to watch.
Originally incorporated in 1997 as a technology spin-out from SRI, the company is now located on Delaware Avenue, in Santa Cruz.
Good news to start the new year
Last month, SomaGenics announced several items of good news.
- SomaGenics was recently awarded $2,275,000 in Small Business Innovation Research (SBIR) grants from the NIH to further develop and expand its RNA-based technologies in the areas of wound healing, hepatitis delta virus (HDV) therapeutics, microRNA (miRNA) expression profiling, and next-generation sequencing. Read more…
- SomaGenics recently had four patents covering various aspects of its small RNA platform technologies issued or allowed by the US and European Patent Offices. Read more…
- SomaGenics and collaborators recently published exciting results on the efficacy of RNA interference (RNAi) therapeutics against the hepatitis C virus (HCV) based on the company’s sshRNA™ platform. Read more…
For more information:
- SomaGenics website
- Three Somagenics Publications Demonstrate Successful Inhibition of the Hepatitis C Virus by Therapeutic sshRNA™ and Confirm Mechanism of Action
- SomaGenics Receives $2,275,000 in NIH Funding to Develop its RNAi Therapeutics and microRNA Technologies
- SomaGenics Awarded Four Patents Spanning Its miRNA and RNAi Programs
###
Tagged Somagenics